Clinsights uses advanced information systems technology to aggregate population-based clinical outcomes data, and to disseminate this data to device companies and physicians. The company's data collection services include e-registries for clinical research, outcomes databases at key clinical centers, and post-market surveillance studies, and the information is disseminated through specialty websites and Internet-based data systems.Key to Clinsights' approach is building relationships with thought leaders in different clinical specialties, the first of which is interventional cardiology. In this area, Clinsights is working with the Cardiovascular Research Foundation (CRF), sponsors of the leading interventional cardiology conference, the Transcatheter Cardiovascular Therapeutics (TCT) meeting. This partnership has produced Clinsights' first website, TCTMD.com.Clinsights' bet is that it can convince medical device companies of the value of its services, built around the ability to collect and disseminate information, and enhanced by partnerships with leading physicians, in providing a competitive advantage that can help differentiate products and technologies.

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Anti-Angiogenesis, features profiles of Cell Matrix Inc., Kereos Inc., MBT Munich Biotechnology GMBH, Oncology Sciences Corp. and Pivotal BioSciences Inc. Plus these Selected Start-Ups across Health Care: CardioVention Inc., MedEView Inc. and XenoPort Inc.

CardioVention Inc. aims to provide reliable respiratory support during both stopped heart and assisted beating heart surgical procedures without the adverse effects caused by traditional cardiopulmonary bypass systems. Its CORx System minimizes the amount of foreign surface area over which blood must pass, and it is operated with only minimal priming, eliminating the damaging effects of hemodilution.